Foundayo™ (orforglipron)

Description

Foundayo™ (orforglipron) – The Convenient Once-Daily Oral GLP-1 Weight Loss Pill

Discover Foundayo™ (orforglipron), the groundbreaking FDA-approved oral GLP-1 receptor agonist from Eli Lilly that makes sustainable weight management easier than ever. As the only GLP-1 pill you can take any time of day, with or without food, and without water restrictions, Foundayo eliminates the hassle of injections or strict dosing rules associated with other weight loss treatments.

Proven Weight Loss Results with Foundayo

Clinically proven in large Phase 3 trials, Foundayo helps adults with obesity or overweight with weight-related conditions (such as high blood pressure, high cholesterol, or type 2 diabetes risk) achieve significant, long-term results when combined with a reduced-calorie diet and increased physical activity.

• Average weight loss of up to 12.4% (approximately 27 lbs) at the highest dose in key studies.
• Many participants achieved 10%+, 15%+, or even 20%+ body weight reduction.
• Additional benefits include improved waist circumference, blood pressure, triglycerides, and cholesterol levels.

Foundayo works by mimicking the natural GLP-1 hormone to help regulate appetite, slow digestion, and promote feelings of fullness — supporting consistent progress without the daily disruption of injectable therapies.

Why Choose Foundayo for Weight Management?

• True convenience: A small, once-daily tablet with no food, water, or timing restrictions — perfect for busy lifestyles.
• Flexible dosing: Starts at 0.8 mg and titrates up to a maximum of 17.2 mg based on your response and tolerability.
• Non-peptide, small-molecule formula: Innovative oral option designed for better everyday adherence compared to traditional GLP-1 treatments.
• Long-term weight maintenance: Helps you not just lose excess weight but keep it off as part of a comprehensive plan.

Important Safety Information Foundayo™ (orforglipron) carries a boxed warning for the risk of thyroid C-cell tumors (including medullary thyroid carcinoma). It should not be used by people with a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Common side effects are mostly mild to moderate gastrointestinal issues (nausea, diarrhea, vomiting, constipation) that often improve over time. Always consult your healthcare provider to determine if Foundayo is right for you.

Who Can Benefit from Foundayo?

Foundayo is prescribed for adults with:

• Obesity (BMI ≥ 30), or
• Overweight (BMI ≥ 27) with at least one weight-related medical problem.

It is not for use in people with type 1 diabetes or as a short-term “quick fix.” Pair it with healthy eating and regular exercise for the best outcomes.

Take the next step toward a healthier you with Foundayo (orforglipron) — the flexible, effective oral weight loss solution that fits your life. Talk to your doctor or access it through LillyDirect® and participating pharmacies today.